Your browser doesn't support javascript.
loading
Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer.
Elander, N O; Aughton, K; Ghaneh, P; Neoptolemos, J P; Palmer, D H; Cox, T F; Campbell, F; Costello, E; Halloran, C M; Mackey, J R; Scarfe, A G; Valle, J W; McDonald, A C; Carter, R; Tebbutt, N C; Goldstein, D; Shannon, J; Dervenis, C; Glimelius, B; Deakin, M; Charnley, R M; Anthoney, Alan; Lerch, M M; Mayerle, J; Oláh, A; Büchler, M W; Greenhalf, W.
Affiliation
  • Elander NO; From the Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Aughton K; From the Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Ghaneh P; From the Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Neoptolemos JP; The Department of Surgery, University of Heidelberg, Heidelberg, Germany.
  • Palmer DH; From the Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Cox TF; From the Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Campbell F; From the Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Costello E; From the Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Halloran CM; From the Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
  • Mackey JR; Cross Cancer Institute and University of Alberta, Alberta, Canada.
  • Scarfe AG; Cross Cancer Institute and University of Alberta, Alberta, Canada.
  • Valle JW; University of Manchester/The Christie NHS Foundation Trust, Manchester, UK.
  • McDonald AC; The Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK.
  • Carter R; Glasgow Royal Infirmary, Glasgow, Scotland, UK.
  • Tebbutt NC; Austin Health, Melbourne, Australia.
  • Goldstein D; Prince of Wales hospital and Clinical School University of New South Wales, New South Wales, Australia.
  • Shannon J; Nepean Cancer Centre and University of Sydney, Sydney, Australia.
  • Dervenis C; The Agia Olga Hospital, Athens, Greece.
  • Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Deakin M; University Hospital, North Staffordshire, UK.
  • Charnley RM; Freeman Hospital, Newcastle upon Tyne, UK.
  • Anthoney A; St James's University Hospital, Leeds, UK.
  • Lerch MM; Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.
  • Mayerle J; Department of Medicine II, University Hospital of the Ludwig-Maximilians-University, Munich, Germany.
  • Oláh A; The Petz Aladar Hospital, Gyor, Hungary.
  • Büchler MW; The Department of Surgery, University of Heidelberg, Heidelberg, Germany.
  • Greenhalf W; From the Cancer Research U.K. Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK. greenhaf@liv.ac.uk.
Br J Cancer ; 118(7): 947-954, 2018 04.
Article in En | MEDLINE | ID: mdl-29515256
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal / Equilibrative Nucleoside Transporter 1 / Dihydrouracil Dehydrogenase (NADP) Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2018 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal / Equilibrative Nucleoside Transporter 1 / Dihydrouracil Dehydrogenase (NADP) Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2018 Type: Article Affiliation country: United kingdom